Joaquim José Coutinho Ferreira
AuthID: R-000-7JF
341
TITLE: Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease. Effect of Opicapone Single-Doses in Patients With Parkinson Disease Full Text
AUTHORS: Jose Francisco Rocha; Joaquim J Ferreira; Amilcar Falcao; Ana Santos; Roberto Pinto ; Teresa Nunes; Luis Almeida; Patricio Soares da Silva;
PUBLISHED: 2016, SOURCE: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, VOLUME: 5, ISSUE: 3
AUTHORS: Jose Francisco Rocha; Joaquim J Ferreira; Amilcar Falcao; Ana Santos; Roberto Pinto ; Teresa Nunes; Luis Almeida; Patricio Soares da Silva;
PUBLISHED: 2016, SOURCE: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, VOLUME: 5, ISSUE: 3
342
TITLE: Association Between Body Mass Index and Parkinson Disease
AUTHORS: Rita Cardoso; Diana Miranda; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: JAMA NEUROLOGY, VOLUME: 73, ISSUE: 7
AUTHORS: Rita Cardoso; Diana Miranda; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: JAMA NEUROLOGY, VOLUME: 73, ISSUE: 7
343
TITLE: A systematic review of the characteristics and validity of monitoring technologies to assess Parkinson's disease (vol 13 , 24, 2015) Full Text
AUTHORS: Godinho, C; Domingos, J; Cunha, G; Santos, AT; Fernandes, RM; Abreu, D; Goncalves, N; Matthews, H; Isaacs, T; Duffen, J; Al Jawad, A; Larsen, F; Serrano, A; Weber, P; Thoms, A; Sollinger, S; Graessner, H; Maetzler, W; Ferreira, JJ;
PUBLISHED: 2016, SOURCE: JOURNAL OF NEUROENGINEERING AND REHABILITATION, VOLUME: 13, ISSUE: 1
AUTHORS: Godinho, C; Domingos, J; Cunha, G; Santos, AT; Fernandes, RM; Abreu, D; Goncalves, N; Matthews, H; Isaacs, T; Duffen, J; Al Jawad, A; Larsen, F; Serrano, A; Weber, P; Thoms, A; Sollinger, S; Graessner, H; Maetzler, W; Ferreira, JJ;
PUBLISHED: 2016, SOURCE: JOURNAL OF NEUROENGINEERING AND REHABILITATION, VOLUME: 13, ISSUE: 1
344
TITLE: New methods for the assessment of Parkinson's disease (2005 to 2015): A systematic review Full Text
AUTHORS: Sanchez Ferro, A; Elshehabi, M; Godinho, C; Salkovic, D; Hobert, MA; Domingos, J; van Uem, JMT; Ferreira, JJ; Maetzler, W;
PUBLISHED: 2016, SOURCE: MOVEMENT DISORDERS, VOLUME: 31, ISSUE: 9
AUTHORS: Sanchez Ferro, A; Elshehabi, M; Godinho, C; Salkovic, D; Hobert, MA; Domingos, J; van Uem, JMT; Ferreira, JJ; Maetzler, W;
PUBLISHED: 2016, SOURCE: MOVEMENT DISORDERS, VOLUME: 31, ISSUE: 9
INDEXED IN: 
Scopus 
WOS
Scopus WOS IN MY: 
ORCID
ORCID345
TITLE: Twelve-week sensor assessment in Parkinson's disease: Impact on quality of life. Wearables and Quality of Life in PD Full Text
AUTHORS: Janet M T van Uem; Katrin S Maier; Svenja Hucker; Olga Scheck; Markus A Hobert; Ana Teresa Santos; Oyvind Fagerbakke; Frank Larsen; Joaquim J Ferreira; Walter Maetzler;
PUBLISHED: 2016, SOURCE: MOVEMENT DISORDERS, VOLUME: 31, ISSUE: 9
AUTHORS: Janet M T van Uem; Katrin S Maier; Svenja Hucker; Olga Scheck; Markus A Hobert; Ana Teresa Santos; Oyvind Fagerbakke; Frank Larsen; Joaquim J Ferreira; Walter Maetzler;
PUBLISHED: 2016, SOURCE: MOVEMENT DISORDERS, VOLUME: 31, ISSUE: 9
346
TITLE: Reply to letter: Exogenous melatonin for Parkinson's disease: 'Waking up' to the need for further trials Full Text
AUTHORS: Tiago Martins Rodrigues; Ana Castro Caldas; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 29
AUTHORS: Tiago Martins Rodrigues; Ana Castro Caldas; Joaquim J Ferreira;
PUBLISHED: 2016, SOURCE: PARKINSONISM & RELATED DISORDERS, VOLUME: 29
347
TITLE: LMNA-associated congenital muscular dystrophy: 3 cases presenting dropped head syndrome Full Text
AUTHORS: Ferreira, J; Ribeiro, M; Moreno, T;
PUBLISHED: 2016, SOURCE: 21st International Congress of the World-Muscle-Society in NEUROMUSCULAR DISORDERS, VOLUME: 26
AUTHORS: Ferreira, J; Ribeiro, M; Moreno, T;
PUBLISHED: 2016, SOURCE: 21st International Congress of the World-Muscle-Society in NEUROMUSCULAR DISORDERS, VOLUME: 26
INDEXED IN: WOS
WOS348
TITLE: Pimavanserin for the treatment of Parkinson's disease psychosis
AUTHORS: Chendo, I; Ferreira, JJ;
PUBLISHED: 2016, SOURCE: EXPERT OPINION ON PHARMACOTHERAPY, VOLUME: 17, ISSUE: 15
AUTHORS: Chendo, I; Ferreira, JJ;
PUBLISHED: 2016, SOURCE: EXPERT OPINION ON PHARMACOTHERAPY, VOLUME: 17, ISSUE: 15
349
TITLE: Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations Full Text
AUTHORS: Mestre, TA; van Duijn, E; Davis, AM; Bachoud Levi, AC; Busse, M; Anderson, KE; Ferreira, JJ; Mahlknecht, P; Tumas, V; Sampaio, C; Goetz, CG; Cubo, E; Stebbins, GT; Martinez Martin, P;
PUBLISHED: 2016, SOURCE: MOVEMENT DISORDERS, VOLUME: 31, ISSUE: 10
AUTHORS: Mestre, TA; van Duijn, E; Davis, AM; Bachoud Levi, AC; Busse, M; Anderson, KE; Ferreira, JJ; Mahlknecht, P; Tumas, V; Sampaio, C; Goetz, CG; Cubo, E; Stebbins, GT; Martinez Martin, P;
PUBLISHED: 2016, SOURCE: MOVEMENT DISORDERS, VOLUME: 31, ISSUE: 10
350
TITLE: Clinical pharmacology review of opicapone for the treatment of Parkinson's disease
AUTHORS: Fabbri, M; Rosa, MM; Ferreira, JJ;
PUBLISHED: 2016, SOURCE: NEURODEGENERATIVE DISEASE MANAGEMENT, VOLUME: 6, ISSUE: 5
AUTHORS: Fabbri, M; Rosa, MM; Ferreira, JJ;
PUBLISHED: 2016, SOURCE: NEURODEGENERATIVE DISEASE MANAGEMENT, VOLUME: 6, ISSUE: 5
